- Category
- Micro (2021-22)
- Udyam number
- UDYAM-PB-12-0032744

Gursimar Pharma Private Limited
About Gursimar Pharma Private Limited
Data last updated:
Gursimar Pharma Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24299PB2020PTC051553. Its GSTIN is 03AAICG4328C1Z3 (Punjab).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Pawitter Grewal Singh and Gurmeet Kaur Grewal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ludhiana, Punjab.
As per MCA filings, the company has open charges of ₹4.71 Cr on record.
Gursimar Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-12-0032744).
Company details
Recognitions & Rankings of Gursimar Pharma
Contact details
Gursimar Pharma Private Limited's registered office is in Ludhiana, Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressV. & P. O. Tibba H.B. No. 249 Near Gurdwara Shree Somasar Sahib Sahne, Wal, Ludhiana, Punjab, India – 141120
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gursimar Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gursimar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Gursimar Pharma Private Limited
FY 2025 filings availableGursimar Pharma Private Limited reported revenue of ₹16 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gursimar Pharma Private Limited, buy the company report.
Board of directors of Gursimar Pharma Private Limited
Gursimar Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawitter Grewal Singh Also directs: Pawitter India Private Limited | Director | 24 Sep 2020 | 6 Years 1 Months | Current |
| Gurmeet Kaur Grewal Also directs: Pawitter India Private Limited | Director | 02 Aug 2020 | 6 Years 3 Months | Current |
| Simarjot Singh Grewal | Director | 02 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Gursimar Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sereno Life Sciences Private Limited | ₹41 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Vav Biocos Private Limited | ₹37 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Pragna Fine Chem Private Limited | ₹32 (FY 2025) | -100.0% | Ankleshwar, Gujarat, India | |||
| Aretesynth Chemistry Private Limited | ₹25 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Synbiopro Nutraceutix (OPC) Private Limited | ₹18 (FY 2024) | Mysore, Karnataka, India | ||||
| Gursimar Pharma Private Limitedthis company | ₹16 (FY 2025) | Ludhiana, Punjab, India | ||||
| B R Laboratories Limited | ₹11 (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Brigid Remedies Private Limited | ₹10 (FY 2024) | Bangalore, Karnataka, India | ||||
| Medaffirm Pharmaceuticals Private Limited | ₹9 (FY 2022) | Mumbai, Maharashtra, India | ||||
| Abrar India Chemicals Private Limited | ₹5 (FY 2025) | -100.0% | Panvel, Maharashtra, India | |||
| Leaf2life Wellness Industries Private Limited | ₹2 (FY 2022) | Delhi, India |
To see the full peer comparison of Gursimar Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2023 | 100761330 | Hdfc Bank Limited | ₹4.71 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Gursimar Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gursimar Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gursimar Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAICG4328C1Z3 | Punjab | Active | 24 Feb 2021 |
To see the full GST registrations and return filing status of Gursimar Pharma Private Limited, buy the company report.
Recent activity
Gursimar Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Pawitter Grewal Singh ceased to be Additional Director on 31 Dec 2021.
Frequently asked questions
Gursimar Pharma is an active private limited company based in Ludhiana, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 August 2020 (6+ years old) and is registered under CIN U24299PB2020PTC051553.
Gursimar Pharma has 3 current directors:
- Pawitter Grewal Singh - Director
- Gurmeet Kaur Grewal - Director
- Simarjot Singh Grewal - Director
The latest financial statements of Gursimar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Gursimar Pharma is 03AAICG4328C1Z3, registered in Punjab.
The CIN (Corporate Identification Number) of Gursimar Pharma is U24299PB2020PTC051553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gursimar Pharma was incorporated on 02 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Gursimar Pharma by revenue are Sereno Life Sciences Private Limited, Vav Biocos Private Limited, Pragna Fine Chem Private Limited, Aretesynth Chemistry Private Limited, Synbiopro Nutraceutix (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pawitter Grewal Singh ceased to be Additional Director on 31 Dec 2021. Pawitter Grewal Singh was appointed as Director on 24 Sep 2020. Gurmeet Kaur Grewal was appointed as Director on 02 Aug 2020. Gursimar Pharma has 4 board changes on record in total.
Yes, Gursimar Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-12-0032744).
The registered office of Gursimar Pharma is at V. & P. O. Tibba H.B. No. 249 Near Gurdwara Shree Somasar Sahib Sahne, Wal, Ludhiana, Punjab, India – 141120.
Gursimar Pharma operates in the pharma industry, in the drug formulation and development segment.

